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Research into the etiology of obesity may provide novel or better means for
treatment or prevention. However, obesity is more complex than originally
thought and research might involve various disciplines ranging from genetics,
proteomics and metabolomics to public health and social sciences. This thesis
provides more insight on how molecular and genetic information may assist the
regulation of weight.
Scientific gain of this thesis
In this thesis we have found that:
(1) We found that during weight loss, adipocytes increase their capacity for
glucose uptake by reduced GLUT4 scavenging and increase their
uptake of fatty acids. In other words, they are preparing themselves to
get more energy in and store fat again, which will contribute to weight
regain. When we can further prove this hypothesis, such knowledge will
enlarge the awareness of people that after weight loss they need to
take extra measures to prevent weight regain. “A very low calorie diet
makes adipocytes scream for fat”
(2) We have shown that mature adipocytes spend a lot of their energy on
sustaining and renewing the extracellular matrix (ECM). When
adipocytes lose fat, mechanical stress builds up between the ECM and
the cell. Refilling of the adipocytes removes adipocyte cellular stress.
Studying the ECM during weight loss may lead to the identification of
risk markers for weight regain after weight loss.
(3) Proteomics of adipocytes during weight loss has provided candidates
for genetic association studies, which may lead to the identification of
genetic risk factors for weight gain and regain.
(4) The investigated single nucleotide polymorphisms or so called SNPs in
FTO in men and MMP2 in women are associated with weight gain over
a 10 year follow-up period. A genetic risk profile could be generated to
select people that are at high risk of weight gain, who can then be given
better guidance of weight regulation.
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Innovation
The present thesis presents various novel findings and insight. We were able to
use proteomics to show the great devotion of adipocytes to maintaining their
extracellular matrix, which is in line with an active role of the ECM in the model
that proposes adipocyte cellular stress as a driver of weight regain. Further we
were able to use a systems proteomics approach to get an overview of the
various lipid and glucose handling segments of the adipocyte cellular
metabolism. This resulted in the detection of several biomarkers for weight loss-
maintenance. Further, the importance of a molecular mechanism of glucose
uptake-regulation in the regulation of adipocyte lipid turnover was revealed
including the action of aldolase, annexinA2, and tubulinB5. Importantly, our
observations showed that during weight loss, adipocytes prepare for uptake of
glucose and fatty acids, which provides a risk condition for weight regain after
weight loss. It is important that weight loss candidates are aware of this
response of their fat tissue. Further, in this thesis we have shown that
proteomics analysis can provide candidate proteins/genes for genetic risk
assessment via cohort studies. Several genetic biomarkers were found in this
thesis with risk alleles for long term weight gain in men and women. These
polymorphisms and the found biomarkers could add to a genetic risk profile for
weight regulation. A gender difference as observed here is not uncommon for
research on weight regulation, but it underscores the importance for setting up
sex-specific guidelines for weight loss and maintenance.
Stakeholders in regard to knowledge application
The most important target group is society itself. The scientific gain of this thesis
will on the long term help to fight obesity by treating the overweight and obese
subjects for weight loss. As such it will contribute to the reduction of the health
burden for society. In fact, our knowledge can be incorporated with the current
treatment and other new developments to offer a specific, personalized
guideline to subjects who aim to lose weight. This will enhance the efficiency of
the weight loss treatment and of weight maintenance. For example, subjects
with a genetic profile predisposing to long-term weight gain should receive a
more stringent and/or frequent guidance than those with a low number of
genetic risk polymorphisms. To ultimately achieve this, high quality prediction
models are a necessity, because the genetic predisposition of overweight and
obesity is extremely complex with a great deal of individual genetic variation.
Such models can be more easily worked out by collaborative actions between
research groups and companies to explore large-scale genome data.
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Dissemination
Knowledge dissemination can be done by delivering prediction models and
treatment guidelines to trained dieticians, specialists of hospital and obesity
clinics such as Co-Eur (http://co-eur.com). Also it is possible to compose and
monitor a complete overview of the health status and personalized guidelines
for subjects, for instance in collaboration with companies such as Pre-Scan, a
company specialized in preventive medical research (http://www.prescan.nl).
Alternatively, the newly gained knowledge can be a starting point of a spin-off
company of the university. The goal of such an undertaking would be
personalized nutrition, a tailor made nutrition advice, which is based on the
genetic, proteomics and metabolomics background of the subject. This tailor
made advice can be of interest for health insurance companies. It could reduce
the health care costs by combating the obesity epidemic. A good example of the
possibilities of personalized nutrition is the use of plant sterol containing food
products to lower the plasma cholesterol level [4].
It should be realized that using knowledge from the present thesis in setting
up/supplying agencies for personalized advice on weight loss/maintenance that
the use of genomic and genetic information is subject to ethical regulation,
which may restrict the actual applications. One of the dangers is the chance of
unexpected findings such as genetic predisposition to life-threatening conditions
in the genetic data. On the other hand, it may be regarded a positive aspect of
genetic analysis that such risk can be discovered before actual symptoms
occur, but this is only beneficial if treatment is available. Those and other
questions have still to be worked out for a complex trait as overweight and
obesity. One example is 23andMe, a company giving personalized advice
based on genome variation, which last year was severely restricted in their
commercial activities because of privacy reasons.
Summary and realization
Valorization requires collaboration among research groups within and outside
the university and with the industry, which can form the basis for spin-off
companies and knowledge-transfer agencies, in which the social media will play
an important role. This collaboration will provide more data and novel ideas, and
leads to gain more, better and accurate insight in the health and risk condition
of each individual. Our findings are a starting point in this respect, but further
research is needed. Newer techniques like detailed proteome quantification and
exome sequencing are getting better and cheaper. Nowadays it is possible to
get a complete human genome sequenced for 1000 dollar and it will get even
more cheaper in the future. Besides ethical consideration in the application of
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research findings, the data generated by modern techniques is enormous.
Therefore, bioinformatics and biostatistics with a focus on modelling will play a
huge role in the process of from data to application.
A reliable individual predictive profile for weight regulation can be available
within the next 5 years for society. In the end, however, people should still worry
about what they eat and keep sufficient physical activity, because you can’t
change your genes, but you can change your behavior.
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